Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Mexico,Poland,United States,Italy,Australia,Czech Republic,China,Israel,Spain,Germany
nct
Update Il y a 5 ans
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
To compare the disease free survival time and safety of sunitinib with placebo in adjuvant treatment patients at high risk of recurrent kidney cancer after surgery.
Country
Australia
,
China
,
Colombia
,
Czech Republic
,
Denmark
,
France
,
Germany
,
Greece
,
Ireland
,
Israel
,
Italy
,
Korea, Republic of
,
Malaysia
,
Mexico
,
Poland
,
Slovakia
,
Spain
,
Sweden
,
Switzerland
,
Taiwan, Province of China
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
FUTURE 3 Study Extension
The objectives of the FUTURE 3 Study Extension are to evaluate the long-term safety, tolerability and efficacy of the pediatric formulation of bosentan two versus three times a day in children with Pulmonary Arterial Hypertension (PAH).
Country
Australia
,
Belarus
,
China
,
Czech Republic
,
France
,
Germany
,
Hungary
,
India
,
Israel
,
Italy
,
Mexico
,
Netherlands
,
Poland
,
Russian Federation
,
Serbia
,
South Africa
,
Spain
,
Ukraine
,
United States
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
The primary objective of AC-052-373 was to assess the pharmacokinetic (PK) profile of two dosing regimens of the pediatric formulation of bosentan in children with pulmonary arterial hypertension (PAH) <12 years of age.
Country
Australia
,
Belarus
,
China
,
Czech Republic
,
France
,
Germany
,
Hungary
,
India
,
Israel
,
Italy
,
Mexico
,
Netherlands
,
Poland
,
Russian Federation
,
Serbia
,
South Africa
,
Spain
,
Ukraine
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1